Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
161,813,505
-
Total 13F shares
-
117,465,887
-
Share change
-
-2,678,257
-
Total reported value
-
$5,554,573,364
-
Put/Call ratio
-
127%
-
Price per share
-
$47.28
-
Number of holders
-
339
-
Value change
-
-$141,946,284
-
Number of buys
-
132
-
Number of sells
-
188
Institutional Holders of IONIS PHARMACEUTICALS INC - Common Stock (IONS) as of Q1 2020
As of 31 Mar 2020 IONIS PHARMACEUTICALS INC - Common Stock (IONS) had 339 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 117,465,887 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, Bellevue Group AG, BlackRock Inc., Clearbridge Investments, LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/, and Invesco Ltd..
This table shows 342 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.